CIK 0000879407
- Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460408024
- Phone
- +1 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 250,000 shares (grant or award)
- 4 Grant or award General Counsel acquired 70,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 900,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 85,000 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 83,333 shares at $63.50 ($5,291,646)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 183,333 shares at an average $67.15 ($12,310,119)
- 4 Open-market sale Chief Executive Officer sold 50,000 shares at an average $67.33 ($3,366,522)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Chief Financial Officer acquired 12,649 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 37,884 shares at an average $40.85 ($1,547,378)
- 4 Open-market sale Chief Executive Officer sold 56,325 shares at $31.83 ($1,792,825)
- 4 Open-market sale Chief Executive Officer sold 20,000 shares at $28.25 ($565,000)
- 4 Open-market sale Chief Executive Officer sold 112,650 shares at an average $28.54 ($3,215,055)
Page 11 of 25 · 497 filings